MediciNova Announces Plans to Initiate a Clinical Trial of MN-166 (ibudilast) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

    NEXT STORY
    Global Pelvic Inflammatory Disease Therapeutics Market – Growth, Trends, and Forecast (2020 to 2025)
    PREV STORY
    Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients

    author_avatar
    NASDAQ Market News

    SELLAS Life Sciences Announces $10,700,000 Private Placement

    - Financing Will Support Advancement of its Late-Stage Immuno-Oncology Pipeline - - Lead Candidate, ...

    author_avatar
    NASDAQ Market News

    Truman Medical Centers and Cerner Launch Innovation Program to Combat High-Risk Chronic Conditions

    KANSAS CITY, Mo., May 16, 2017 (GLOBE NEWSWIRE) -- Truman Medical Centers (TMC) and ...

    author_avatar
    NASDAQ Market News